OrbiMed Advisors, a Director, Invests $3.75M in ImageneBio Private Placement

summarizeSummary

OrbiMed Advisors, an institutional investor with a board seat, acquired $3.75 million in pre-funded warrants as part of ImageneBio's recently announced private placement, signaling strong confidence.

check_boxKey Events

• Institutional Director Invests

  OrbiMed Advisors, an institutional investor and director, acquired 721,292 pre-funded warrants.

• Significant Capital Infusion

  The purchase represents a $3.75 million investment, part of the company's recent $30 million private placement.

• Strong Vote of Confidence

  This substantial investment from a key backer signals strong confidence in ImageneBio's future.

auto_awesomeAnalysis

This Form 4 details the participation of OrbiMed Advisors, an institutional investor and director, in ImageneBio's $30 million private placement announced on April 13, 2026. OrbiMed acquired 721,292 pre-funded warrants for approximately $3.75 million. This significant investment, representing about 5.8% of the company's market capitalization, demonstrates strong conviction from a key institutional backer and provides crucial capital for the micro-cap biotech company. The purchase price of $5.199 per warrant aligns with the terms of the broader capital raise.